pubmed-article:6362342 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0001645 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0026606 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0005823 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0018810 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C2709058 | lld:lifeskim |
pubmed-article:6362342 | lifeskim:mentions | umls-concept:C0332173 | lld:lifeskim |
pubmed-article:6362342 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:6362342 | pubmed:dateCreated | 1984-2-20 | lld:pubmed |
pubmed-article:6362342 | pubmed:abstractText | In a cross-over study of 52 middle-aged patients with mild to moderate essential hypertension, we have compared the effect and tolerability of 100 mg atenolol and 100 mg metoprolol given once daily. After 1 1/2 and 3 months of treatment, both systolic and diastolic blood pressure 24 hours after drug intake were significantly lower on atenolol. There were no significant differences after 3 months when blood pressure was read 3-4 hours after dose intake. During exercise, systolic blood pressure and heart rate were--at all work-loads--significantly lower on atenolol. Four patients on metoprolol and one patient on atenolol discontinued treatment owing to side-effects. The results support the need for thorough analysis of the duration of action and influence of physical activity and sympathetic tone in comparisons between presumedly equivalent antihypertensive drugs. | lld:pubmed |
pubmed-article:6362342 | pubmed:language | eng | lld:pubmed |
pubmed-article:6362342 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6362342 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6362342 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6362342 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6362342 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6362342 | pubmed:issn | 0001-6101 | lld:pubmed |
pubmed-article:6362342 | pubmed:author | pubmed-author:DanielsonMM | lld:pubmed |
pubmed-article:6362342 | pubmed:author | pubmed-author:SvenssonOO | lld:pubmed |
pubmed-article:6362342 | pubmed:author | pubmed-author:LundkvistLL | lld:pubmed |
pubmed-article:6362342 | pubmed:author | pubmed-author:KjellbergJJ | lld:pubmed |
pubmed-article:6362342 | pubmed:author | pubmed-author:Kuylenstierna... | lld:pubmed |
pubmed-article:6362342 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6362342 | pubmed:volume | 214 | lld:pubmed |
pubmed-article:6362342 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6362342 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6362342 | pubmed:pagination | 381-5 | lld:pubmed |
pubmed-article:6362342 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:meshHeading | pubmed-meshheading:6362342-... | lld:pubmed |
pubmed-article:6362342 | pubmed:year | 1983 | lld:pubmed |
pubmed-article:6362342 | pubmed:articleTitle | Influence of time and physical activity on blood pressure and heart rate during treatment with beta-blocking agents once daily. | lld:pubmed |
pubmed-article:6362342 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6362342 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:6362342 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:6362342 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |